MENU
CYDY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
CytoDyn (CYDY) Ownership - Who owns CytoDyn?
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection... Show more
Profile
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
257.93M
P/E Ratio
N/A
Total Cash
21.34M
Projected Growth
N/A
Total Debt
28.74M
Revenue
N/A
Risk (Beta)
1.63
Dividend Yield
N/A
Total Cash/Share
0.02
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CYDY
Capitalization
258M
P/E Ratio
N/A
Risk (Beta)
1.63
Dividend Yield
N/A
Total Cash
21.3M
Total Cash/Share
0.02
Total Debt
28.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-89.39M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.22M
Current Ratio
0.35
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-8.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-92.22
Shares Held By Institutions
29.8K
Shares Outstanding - Current
1.23B
Total Liabilities
114M
Total Volume MTD
N/A
Value
1
Gain YTD
91.431
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com